OR2H2
gene geneOn this page
Also known as hs6M1-12
Summary
OR2H2 (olfactory receptor family 2 subfamily H member 2, HGNC:8253) is a protein-coding gene on chromosome 6p22.1, encoding Olfactory receptor 2H2 (O95918). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 7932 — RefSeq curated summary.
At a glance
- GWAS associations: 19
- Clinical variants (ClinVar): 37 total
- MANE Select transcript:
NM_007160
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8253 |
| Approved symbol | OR2H2 |
| Name | olfactory receptor family 2 subfamily H member 2 |
| Location | 6p22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | hs6M1-12 |
| Ensembl gene | ENSG00000204657 |
| Ensembl biotype | protein_coding |
| OMIM | 600578 |
| Entrez | 7932 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000383640, ENST00000641840
RefSeq mRNA: 1 — MANE Select: NM_007160
NM_007160
CCDS: CCDS34365
Canonical transcript exons
ENST00000376947 — 0 exons
Expression profiles
Bgee: expression breadth broad, 74 present calls, max score 71.85.
Top tissues by expression
100 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 71.85 | silver quality |
| putamen | UBERON:0001874 | 64.41 | gold quality |
| nucleus accumbens | UBERON:0001882 | 63.68 | gold quality |
| caudate nucleus | UBERON:0001873 | 63.38 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 58.78 | gold quality |
| ventricular zone | UBERON:0003053 | 58.17 | gold quality |
| temporal lobe | UBERON:0001871 | 57.84 | gold quality |
| amygdala | UBERON:0001876 | 57.73 | gold quality |
| cerebellum | UBERON:0002037 | 57.41 | gold quality |
| cerebellar cortex | UBERON:0002129 | 57.27 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 57.18 | gold quality |
| Ammon’s horn | UBERON:0001954 | 56.89 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 55.97 | gold quality |
| right testis | UBERON:0004534 | 55.52 | gold quality |
| brain | UBERON:0000955 | 55.49 | gold quality |
| primary visual cortex | UBERON:0002436 | 55.46 | gold quality |
| sural nerve | UBERON:0015488 | 55.00 | gold quality |
| right frontal lobe | UBERON:0002810 | 54.01 | gold quality |
| left testis | UBERON:0004533 | 53.91 | gold quality |
| testis | UBERON:0000473 | 53.58 | gold quality |
| hypothalamus | UBERON:0001898 | 53.32 | gold quality |
| cerebral cortex | UBERON:0000956 | 53.16 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 52.97 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 52.56 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 52.09 | gold quality |
| frontal cortex | UBERON:0001870 | 51.10 | gold quality |
| substantia nigra | UBERON:0002038 | 50.13 | gold quality |
| colonic epithelium | UBERON:0000397 | 49.99 | gold quality |
| adenohypophysis | UBERON:0002196 | 49.50 | gold quality |
| prefrontal cortex | UBERON:0000451 | 48.76 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.08 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (92): OR2B6 (ENSG00000124657), OR13C9 (ENSG00000136839), OR13C4 (ENSG00000148136), OR2M5 (ENSG00000162727), OR10A5 (ENSG00000166363), OR2D2 (ENSG00000166368), OR2B2 (ENSG00000168131), OR2C1 (ENSG00000168158), OR13J1 (ENSG00000168828), OR10G3 (ENSG00000169208), OR10A3 (ENSG00000170683), OR10A4 (ENSG00000170782), OR10A2 (ENSG00000170790), OR13H1 (ENSG00000171054), OR2K2 (ENSG00000171133), OR2M4 (ENSG00000171180), OR10H2 (ENSG00000171942), OR10H5 (ENSG00000172519), OR10AD1 (ENSG00000172640), OR2Y1 (ENSG00000174339), OR10AG1 (ENSG00000174970), OR2T1 (ENSG00000175143), OR10P1 (ENSG00000175398), OR2T35 (ENSG00000177151), OR2M7 (ENSG00000177186), OR2T12 (ENSG00000177201), OR2T33 (ENSG00000177212), OR2AJ1 (ENSG00000177275), OR2T8 (ENSG00000177462), OR2G3 (ENSG00000177476), OR2G2 (ENSG00000177489), OR2B11 (ENSG00000177535), OR2D3 (ENSG00000178358), OR13D1 (ENSG00000179055), OR10A7 (ENSG00000179919), OR2Z1 (ENSG00000181733), OR2V2 (ENSG00000182613), OR10G7 (ENSG00000182634), OR2T29 (ENSG00000182783), OR2T34 (ENSG00000183310)
Protein
Protein identifiers
Olfactory receptor 2H2 — O95918 (reviewed: O95918)
Alternative names: Hs6M1-12, Olfactory receptor 2H3, Olfactory receptor-like protein FAT11
All UniProt accessions (2): A0A1U9X844, O95918
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_009091* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (37 total): sequence conflict 13, topological domain 8, transmembrane region 7, sequence variant 6, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O95918-F1 | 89.12 | 0.65 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 95–187
Glycosylation sites (1): 3
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 40 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, BROWNE_HCMV_INFECTION_48HR_DN, KEGG_OLFACTORY_TRANSDUCTION, SCHLOSSER_SERUM_RESPONSE_DN, SANSOM_APC_TARGETS_DN, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, RUAN_RESPONSE_TO_TROGLITAZONE_UP, RUAN_RESPONSE_TO_TNF_UP, RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP, BURTON_ADIPOGENESIS_6, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY
GO Biological Process (6): defense response (GO:0006952), mating (GO:0007618), detection of chemical stimulus involved in sensory perception of smell (GO:0050911), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| response to stress | 1 |
| sexual reproduction | 1 |
| multi-organism reproductive process | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
248 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR2H2 | HLA-F | P30511 | 694 |
| OR2H2 | IKZF1 | Q13422 | 694 |
| OR2H2 | IGLL5 | B9A064 | 647 |
| OR2H2 | ZNF311 | Q5JNZ3 | 553 |
| OR2H2 | CENPS | Q8N2Z9 | 545 |
| OR2H2 | MOG | Q16653 | 491 |
| OR2H2 | ZFP57 | Q9NU63 | 491 |
| OR2H2 | INVS | Q9Y283 | 490 |
| OR2H2 | IL4 | P05112 | 470 |
| OR2H2 | MICB | P79525 | 439 |
| OR2H2 | C6orf163 | Q5TEZ5 | 436 |
| OR2H2 | IL2 | P01585 | 435 |
| OR2H2 | CFAP107 | Q8N1D5 | 419 |
| OR2H2 | ATF6B | Q99941 | 412 |
| OR2H2 | MUC22 | E2RYF6 | 389 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OR2H2 | SERPINB8 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (3): OR2H2 (Synthetic Lethality), SERPINB8 (Affinity Capture-MS), LRRC8D (Affinity Capture-MS)
ESM2 similar proteins: A6NH00, O60403, O95371, O95918, P23266, P23267, P23275, P34984, P47881, P47888, P47893, Q15619, Q5JQS5, Q5TZ20, Q60885, Q60891, Q60894, Q6IEZ7, Q7Z3T1, Q8N628, Q8NG76, Q8NG77, Q8NG97, Q8NGA6, Q8NGC4, Q8NGE3, Q8NGE9, Q8NGQ2, Q8NGQ4, Q8NGR4, Q8NGS0, Q8NGT9, Q8NGX9, Q8NGY1, Q8NGZ6, Q8NH02, Q8NH03, Q8NH04, Q8NHB1, Q8VGD6
Diamond homologs: A3KFT3, A4D2G3, A6NH00, A6NL26, A6NM03, O43869, O76000, O76001, O76002, O95006, O95221, O95371, O95918, P0C7N1, P0C7T2, P23274, P23275, P34984, P59922, Q13606, Q13607, Q5TZ20, Q60880, Q60890, Q6IEZ7, Q6IF00, Q8N127, Q8N349, Q8N628, Q8NG75, Q8NG76, Q8NG77, Q8NG80, Q8NG81, Q8NG83, Q8NG84, Q8NG85, Q8NG97, Q8NGC0, Q8NGE5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
37 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 33 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
83 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:29588183:T:A | acceptor_gain | 0.5600 |
| 6:29588131:A:AG | acceptor_gain | 0.5300 |
| 6:29588144:T:A | acceptor_gain | 0.5200 |
| 6:29587553:A:G | donor_gain | 0.4900 |
| 6:29588304:C:G | donor_gain | 0.4500 |
| 6:29588592:C:CA | acceptor_gain | 0.4300 |
| 6:29588158:A:AG | acceptor_gain | 0.4000 |
| 6:29588158:ACCAC:A | acceptor_gain | 0.3900 |
| 6:29588145:G:A | acceptor_gain | 0.3800 |
| 6:29588304:C:CG | donor_gain | 0.3800 |
| 6:29588178:A:G | acceptor_gain | 0.3700 |
| 6:29588258:T:TA | acceptor_gain | 0.3600 |
| 6:29588267:C:CG | donor_gain | 0.3500 |
| 6:29588179:ATGCT:A | acceptor_gain | 0.3400 |
| 6:29588159:C:G | acceptor_gain | 0.3300 |
| 6:29588259:G:A | acceptor_gain | 0.3300 |
| 6:29588462:A:G | donor_gain | 0.3200 |
| 6:29588132:A:G | acceptor_gain | 0.3100 |
| 6:29588303:GC:G | donor_gain | 0.3100 |
| 6:29588459:TGG:T | donor_gain | 0.3100 |
| 6:29588267:C:G | donor_gain | 0.3000 |
| 6:29588476:G:GC | acceptor_gain | 0.3000 |
| 6:29588593:G:A | acceptor_gain | 0.3000 |
| 6:29588177:A:AG | acceptor_gain | 0.2900 |
| 6:29588180:T:TA | acceptor_gain | 0.2900 |
| 6:29588455:C:T | donor_gain | 0.2800 |
| 6:29588460:G:GA | donor_gain | 0.2800 |
| 6:29588477:AG:A | donor_gain | 0.2800 |
| 6:29588478:GG:G | donor_gain | 0.2800 |
| 6:29588636:G:GT | donor_gain | 0.2800 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000019627 (6:29590189 T>C), RS1001196823 (6:29589874 C>A), RS1001616637 (6:29583297 T>C), RS1001649820 (6:29590074 A>T), RS1001767817 (6:29587385 T>C), RS1001953655 (6:29585195 C>A), RS1002089449 (6:29584836 C>G,T), RS1002173425 (6:29585721 A>C), RS1002225913 (6:29585905 A>G), RS1005623527 (6:29583551 G>C), RS1005695503 (6:29583275 T>A,C), RS1005923507 (6:29589507 CTT>C), RS1006589451 (6:29589843 A>C), RS1006624435 (6:29585221 C>A,T), RS1006697735 (6:29584772 C>A)
Disease associations
OMIM: gene MIM:600578 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
19 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004521_112 | Autism spectrum disorder or schizophrenia | 3.000000e-26 |
| GCST004521_171 | Autism spectrum disorder or schizophrenia | 4.000000e-14 |
| GCST004521_263 | Autism spectrum disorder or schizophrenia | 7.000000e-17 |
| GCST004521_268 | Autism spectrum disorder or schizophrenia | 7.000000e-12 |
| GCST004521_295 | Autism spectrum disorder or schizophrenia | 6.000000e-18 |
| GCST004521_56 | Autism spectrum disorder or schizophrenia | 1.000000e-22 |
| GCST004521_58 | Autism spectrum disorder or schizophrenia | 1.000000e-17 |
| GCST004521_80 | Autism spectrum disorder or schizophrenia | 1.000000e-15 |
| GCST010142_16 | Fish- and plant-related diet | 2.000000e-10 |
| GCST010142_19 | Fish- and plant-related diet | 4.000000e-10 |
| GCST010142_34 | Fish- and plant-related diet | 7.000000e-09 |
| GCST010142_35 | Fish- and plant-related diet | 8.000000e-09 |
| GCST010142_42 | Fish- and plant-related diet | 1.000000e-08 |
| GCST010142_7 | Fish- and plant-related diet | 3.000000e-12 |
| GCST010702_75 | Subcortical volume (MOSTest) | 3.000000e-11 |
| GCST010703_272 | Brain morphology (MOSTest) | 7.000000e-16 |
| GCST90000025_476 | Appendicular lean mass | 9.000000e-21 |
| GCST90011898_140 | Alanine aminotransferase levels | 2.000000e-10 |
| GCST90011900_181 | Serum alkaline phosphatase levels | 1.000000e-08 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008111 | diet measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0004980 | appendicular lean mass |
| EFO:0004533 | alkaline phosphatase measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sulforaphane | increases expression | 1 |
| Resveratrol | decreases expression, affects cotreatment | 1 |
| Acetaminophen | decreases expression | 1 |
| Amphotericin B | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Valproic Acid | affects expression | 1 |
| Asbestos, Serpentine | increases methylation | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.